Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Docetaxel-induced Flagellate Erythema - Case Report and Brief Review

Author(s): Jerbi Asma*, Kastalli Sarrah, Charfi Ons, Dhaghfous Riadh and El Aidli Sihem

Volume 18, Issue 3, 2023

Published on: 16 September, 2022

Page: [386 - 388] Pages: 3

DOI: 10.2174/1574886317666220613155550

Price: $65

Abstract

Introduction: Flagellate erythema is a distinctive morphologic reaction pattern recognized by whiplash-like pruritic erythematous eruption. It is usually encountered in patients receiving bleomycin. Only one case of docetaxel-induced flagellate erythema is reported in the literature.

Case Report: Herein, we report a rare case of docetaxel-induced flagellate erythema in a 53 years old woman with no particular medical history treated with docetaxel for metastatic adenocarcinoma of her right breast. Seven days after the third course, she developed multiple lineal and parallel pruritic erythematous streaks mainly on her chest and abdomen. The cutaneous erythema disappeared gradually over 10 days, leaving hyper-pigmented post-inflammatory linear scars lasting two weeks. The same reaction reappeared after the fourth and the fifth docetaxel course.

Conclusion: Flagellate erythema has been reported as an adverse drug reaction secondary to several antineoplastic molecules, including docetaxel. Further studies are needed to discover its underlying mechanisms in order to figure out better treatment plans and prevention.

Keywords: flagellate, erythema, docetaxel, chemotherapy, pharmacovigilance, bleomycin

« Previous Next »
[1]
Mendonça FMI, Márquez-García A, Méndez-Abad C, et al. Flagellate dermatitis and flagellate erythema: Report of 4 cases. Int J Dermatol 2017; 56(4): 461-3.
[http://dx.doi.org/10.1111/ijd.13523] [PMID: 28102584]
[2]
Yamamoto T. Flagellate erythema induced by cisplatin. Clin Exp Dermatol 2016; 41(5): 562-3.
[http://dx.doi.org/10.1111/ced.12830] [PMID: 26931175]
[3]
Lim D, Aussedat M, Maillet-Lebel N, Marcoux D. Flagellate dermatitis in a child most likely secondary to doxorubicin. Pediatr Dermatol 2017; 34(5): e257-9.
[http://dx.doi.org/10.1111/pde.13234] [PMID: 28804924]
[4]
Mahmoud BH, Eide MJ. Bendamustine-induced “flagellate dermatitis”. Dermatol Online J 2012; 18(11): 12.
[http://dx.doi.org/10.5070/D36QJ3649F] [PMID: 23217953]
[5]
Cohen PR. Trastuzumab-associated flagellate erythema: Report in a woman with metastatic breast cancer and review of antineoplastic therapy-induced flagellate dermatoses. Dermatol Ther 2015; 5(4): 253-64.
[http://dx.doi.org/10.1007/s13555-015-0085-2] [PMID: 26506993]
[6]
Tallon B, Lamb S. Flagellate erythema induced by docetaxel. Clin Exp Dermatol 2008; 33(3): 276-7.
[http://dx.doi.org/10.1111/j.1365-2230.2007.02633.x] [PMID: 18201264]
[7]
Miremont-Salamé G, Théophile H, Haramburu F, Bégaud B. Causality assessment in pharmacovigilance: The French method and its successive updates. Therapie 2016; 71(2): 179-86.
[http://dx.doi.org/10.1016/j.therap.2016.02.010] [PMID: 27080836]
[8]
Chew L, Chuen VSL. Cutaneous reaction associated with weekly docetaxel administration. J Oncol Pharm Pract 2009; 15(1): 29-34.
[http://dx.doi.org/10.1177/1078155208096111] [PMID: 18753180]
[9]
Mota GD, Penna AMD, Soares RC, Baiocchi OCG. Bleomycin-induced flagellate dermatitis. Rev Bras Hematol Hemoter 2014; 36(4): 297-9.
[http://dx.doi.org/10.1016/j.bjhh.2014.03.001] [PMID: 25031171]
[10]
Ziemer M, Goetze S, Juhasz K, Elsner P. Flagellate dermatitis as a bleomycin-specific adverse effect of cytostatic therapy: A clinical-histopathologic correlation. Am J Clin Dermatol 2011; 12(1): 68-76.
[http://dx.doi.org/10.2165/11537080-000000000-00000] [PMID: 21067249]

Rights & Permissions Print Cite
Article Metrics
4
© 2024 Bentham Science Publishers | Privacy Policy